×
About 108 results
Drug, devices, technologies, and techniques for blood management in minimally invasive ...
https://doi.org/10.1097/IMI.0b013e3182747699
Innovations (Philadelphia, Pa.); Menkis AH, Martin J et. al.

Nov 5th, 2012 - The objectives of this consensus conference were to evaluate the evidence for the efficacy and safety of perioperative drugs, technologies, and techniques in reducing allogeneic blood transfusion for adults undergoing cardiac surgery and to develop evidence-based recommendations for comprehensive perioperative blood management in cardiac surgery, with emphasis on minimally invasive cardiac surg...

Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-ana...
https://doi.org/10.1016/j.ejcts.2008.11.027
European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery; Baker WL, Anglade MW et. al.

Jan 16th, 2009 - Post-cardiothoracic surgery (CTS) complications (e.g. myocardial injury, renal dysfunction, atrial fibrillation) may occur as a result of enhanced systemic inflammation, perhaps provoked by an oxidative stress response. N-acetylcysteine (NAC) is a free radical scavenger antioxidant agent that may attenuate this physiologic response and reduce post-CTS complications. Thus, a meta-analysis was pe...

Current integrated cardiothoracic surgery residents: a Thoracic Surgery Residents Assoc...
https://doi.org/10.1016/j.athoracsur.2014.10.063
The Annals of Thoracic Surgery; Tchantchaleishvili V, LaPar DJ et. al.

Jan 27th, 2015 - After approval by the Thoracic Surgery Residency Review Committee in 2007, 6-year integrated cardiothoracic surgery (I-6) residency programs have gained in popularity. We sought to assess and objectively quantify the level of satisfaction I-6 residents have with their training and to identify areas of improvement for future curriculum development. A completely anonymous, electronic survey was c...

Effectiveness of BoneSeal® on Bone Hemostats in Patients Undergoing Cardiothoracic Surgery
https://clinicaltrials.gov/ct2/show/NCT03085017

Jun 8th, 2017 - A prospective randomized open-label study that will evaluate the effectiveness of the pliable and absorbable bone hemostats (BoneSeal®) composed of synthetic materials and hydroxyapatite on the reduction of bleeding from the sternal bone marrow in patients undergoing Coronary Artery Bypass Grafting, with or without valve replacement or repair. This product will be compared to the similar, curre...

Objective Assessment of Technical Skills in Cardiothoracic Surgery
https://clinicaltrials.gov/ct2/show/NCT01433029

Jan 29th, 2017 - The goal of this research study is to develop a method of rating videos of CAB procedures that will produce a reliable assessment of a cardiothoracic surgical trainee's technical proficiency. In addition, researchers also want to learn if using a video manual to train raters can help improve rater reliability.

Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery
https://clinicaltrials.gov/ct2/show/NCT02112448

Jun 1st, 2017 - Prior to surgery, eligible patients scheduled for surgery will be sent our standard surgery letter (Attachment A) along with our study informational sheet (Attachment B) describing our study. The study informational sheet will have a telephone number to call to set up a phone appointment to discuss the study with the PI should parents have questions not answered on the sheet. During the pre-ope...

Bloodtranfusions After Aortic Surgery
https://clinicaltrials.gov/ct2/show/NCT02299947

Mar 5th, 2018 - Cardiothoracic surgery (CTC) is associated with blood loss and an increased risk for impaired coagulation by the use of a CBP. Coagulation is a process of primary hemostasis by adhesion of trombocytes and aggregation, followed by secondary coagulation and fibrin formation. During CTC fibrinogen is the first coagulation factor which reaches critical concentration necessary for clotting. Point of...

CAM in Post Surgical Management in Cardiothoracic Surgery
https://clinicaltrials.gov/ct2/show/NCT01650363

This is a randomized controlled clinical trial in which the combination of 4 different CAM modalities (Complementary & Alternative Medicine) will be applied during the postoperative period to patients undergoing open heart- or lung surgery and expected to be hospitalized for more than 5 days. Elective and Urgent surgical patients will be randomly assigned to a treatment - and to a control group...

Transfusion Strategies in Pediatric Cardiothoracic Surgery
https://clinicaltrials.gov/ct2/show/NCT00350220

Jun 25th, 2015 - Objective: To compare mean post-operative arterial lactate levels, oxygen utilization, and outcome measures in pediatric patients undergoing cavopulmonary connection managed with two different red blood cell transfusion strategies. Methods: We propose a prospective, randomized clinical trial of sixty-six pediatric patients with cyanotic, complex congenital cardiac disease undergoing cavopulmona...

Effects of Thymectomy During Cardiothoracic Surgery
https://clinicaltrials.gov/ct2/show/NCT00263120

Aug 23rd, 2016 - The thymus is known to be the site of T cell development in humans. Due to its location in the chest in front of the heart, incidental thymecomy is commonly performed during cardiothoracic surgery, especially in infants and children, so that surgeons may gain access to the surgical field. This practice has been considered safe because it was thought that the thymus is inactive after birth. Howe...

Precision and accuracy: comparison of point-of-care and laboratory glucose concentratio...
https://doi.org/10.1097/JCN.0b013e31820a7bf4
The Journal of Cardiovascular Nursing; Denfeld QE, Goodell TT et. al.

Jan 25th, 2011 - There have been variable results on the practice of tight glycemic control, and studies have demonstrated that point-of-care (POC) glucometers have variable accuracy. The purpose of this study was to determine the difference between blood glucose concentrations obtained from POC glucometers as compared with laboratory results in cardiothoracic surgery (CTS) patients. This was a descriptive stud...

The heart of the matter: Outcome reporting bias and registration status in cardio-thora...
https://doi.org/10.1016/j.ijcard.2016.11.098
International Journal of Cardiology; Wiebe J, Detten G et. al.

Nov 14th, 2016 - Our objective is to compare registered outcomes to published reports; to evaluate for discrepancies favoring statistically significant outcomes; to examine funding source and likelihood of outcome reporting bias; and to evaluate for any temporal trends in outcome reporting bias. PubMed was searched for randomized controlled trials published between 2008 and 2015 from 4 high impact cardio-thorac...

Association between perioperative NSAID use and post-cardiothoracic surgery atrial fibr...
https://doi.org/10.1185/030079908x280671
Current Medical Research and Opinion; Ruffin RT, Kluger J et. al.

Mar 12th, 2008 - Nonsteroidal anti-inflammatory drug (NSAID) use may reduce the incidence of post-cardiothoracic surgery (CTS) atrial fibrillation (AF). The cerebrovascular and cardiovascular safety of using NSAIDs for post-CTS AF has not been determined. To evaluate whether NSAIDs could reduce the incidence of post-CTS atrial fibrillation without increasing patients' risk of stroke or myocardial infarction (MI...

Usefulness of laboratory values in predicting effectiveness of recombinant factor VIIa ...
https://doi.org/10.2146/ajhp120651
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists; Gruber SN, Volles DF

Aug 14th, 2013 - The results of a study to determine whether certain laboratory values can predict the effectiveness of recombinant factor VIIa (rFVIIa) therapy to control postoperative bleeding in surgical patients are presented. In a retrospective observational study at a large university hospital, the records of all adult patients on the cardiothoracic surgery (CTS) and general or trauma surgery (GTS) units ...

Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery.
https://doi.org/10.2146/ajhp100703
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists; Colby JA, Chen WT et. al.

Aug 22nd, 2011 - The effect of ascorbic acid on inflammatory markers after cardiothoracic surgery (CTS) was studied. In this randomized, double-blind, placebo-controlled trial, patients undergoing cardiopulmonary bypass graft surgery or valve replacement surgery from April 2009 through March 2010 at Hartford Hospital were randomized to receive ascorbic acid (2-g loading dose followed by 500 mg every 12 hours) o...

Surgical Site Infection After Pediatric Cardiothoracic Surgery.
https://doi.org/10.1177/2150135116674467
World Journal for Pediatric & Congenital Heart Surgery; Sochet AA, Cartron AM et. al.

Dec 29th, 2016 - Surgical site infection (SSI) occurs in 0.25% to 6% of children after cardiothoracic surgery (CTS). There are no published data regarding the financial impact of SSI after pediatric CTS. We sought to determine the attributable hospital cost and length of stay associated with SSI in children after CTS. We performed a retrospective, matched cohort study in a 26-bed cardiac intensive care unit (CI...

Role of irbesartan in prevention of post-coronary artery bypass graft atrial fibrillation.
https://doi.org/10.2165/11587160-000000000-00000
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions; El-Haddad MA, Zalawadiya SK et. al.

May 31st, 2011 - Atrial fibrillation (AF) is a common complication of cardiothoracic surgery (CTS). Existing evidence about the potential protective role of angiotensin II type 1 receptor antagonists (angiotensin receptor blockers [ARBs]) for post-CTS AF has been limited and conflicting. In this single-blind, open-label, randomized prospective pilot study, we evaluated the potential protective role of irbesarta...

Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver d...
https://doi.org/10.1055/s-0032-1325733
Endoscopy Voigtländer T, Negm AA et. al.

Oct 30th, 2012 - Secondary sclerosing cholangitis in critically ill patients (SSC - CIP) is an underdiagnosed emerging disease. The aim of this study was to characterize clinical features and prognostic factors for mortality in SSC - CIP. This retrospective study included 54 patients who were diagnosed via endoscopic retrograde cholangiopancreatography (ERCP) after cardiothoracic surgery (n = 21), sepsis (n = 1...

The golden age of minimally invasive cardiothoracic surgery: current and future perspec...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134935
Future Cardiology; Iribarne A, Easterwood R et. al.

Jun 1st, 2011 - Over the past decade, minimally invasive cardiothoracic surgery (MICS) has grown in popularity. This growth has been driven, in part, by a desire to translate many of the observed benefits of minimal access surgery, such as decreased pain and reduced surgical trauma, to the cardiac surgical arena. Initial enthusiasm for MICS was tempered by concerns over reduced surgical exposure in highly comp...

Use of preoperative CHA2 DS2 -VASc score to predict the risk of atrial fibrillation aft...
https://doi.org/10.1002/phar.1235
Pharmacotherapy Baker WL, Coleman CI et. al.

May 7th, 2013 - To evaluate whether the preoperative CHA2 DS2 -VASc score predicts the risk of atrial fibrillation (AF) after cardiothoracic surgery (CTS). Retrospective, nested case-control study. A total of 560 patients undergoing coronary artery bypass grafting and/or valvular surgery from the Atrial Fibrillation Suppression Trials I, II, and III. All variables showing a univariate association (p≤0.20) with...